Evidence map›Paper›PMID 42032295›Full record

ArticleCell death and differentiation2026

Correction: The tumor suppressor protein PML controls apoptosis induced by the HIV-1 envelope.

J-L Perfettini, R Nardacci, C Séror, M Bourouba, F Subra, L Gros, G Manic, A Amendola, P Masdehors, F Rosselli and 6 more

Abstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Cell death and differentiation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors.

J-L Perfettini *INSERM U848, Institut Gustave Roussy, Université Paris Sud, Paris 11, 39 rue Camille-Desmoulins, F-94805, Villejuif, France.
R Nardacci *National Institute for Infectious Diseases 'Lazzaro Spallanzani', Via Portuense 292, 00149, Rome, Italy.
C SérorINSERM U848, Institut Gustave Roussy, Université Paris Sud, Paris 11, 39 rue Camille-Desmoulins, F-94805, Villejuif, France.
M BouroubaINSERM U848, Institut Gustave Roussy, Université Paris Sud, Paris 11, 39 rue Camille-Desmoulins, F-94805, Villejuif, France.
F SubraCNRS UMR 8113 LBPA, Ecole Normale Supérieure de Cachan, 61 avenue du Président Wilson, 94230, Cachan, France.
L GrosCNRS UMR 8113 LBPA, Ecole Normale Supérieure de Cachan, 61 avenue du Président Wilson, 94230, Cachan, France.
G ManicINSERM U848, Institut Gustave Roussy, Université Paris Sud, Paris 11, 39 rue Camille-Desmoulins, F-94805, Villejuif, France.
A AmendolaNational Institute for Infectious Diseases 'Lazzaro Spallanzani', Via Portuense 292, 00149, Rome, Italy.
P MasdehorsAntiviral Immunity, Biotherapy and Vaccine Unit, Department of Infection and Epidemiology, Institut Pasteur, 28 rue du Dr. Roux, 75724, Paris Cedex 15, France.
F RosselliCNRS FRE2939, Institut Gustave Roussy, Université Paris Sud, Paris 11, 39 rue Camille-Desmoulins, F-94805, Villejuif, France.
D M OjciusSchool of Natural Sciences, University of California, Merced, CA, USA.
C AuclairCNRS UMR 8113 LBPA, Ecole Normale Supérieure de Cachan, 61 avenue du Président Wilson, 94230, Cachan, France.
H de ThéCNRS UPR9051, Université de Paris VII, Hôpital St. Louis, 1 avenue Claude Vellefaux, 75475, Paris Cedex 10, France.
M-L GougeonAntiviral Immunity, Biotherapy and Vaccine Unit, Department of Infection and Epidemiology, Institut Pasteur, 28 rue du Dr. Roux, 75724, Paris Cedex 15, France.
M PiacentiniNational Institute for Infectious Diseases 'Lazzaro Spallanzani', Via Portuense 292, 00149, Rome, Italy.
G KroemerINSERM U848, Institut Gustave Roussy, Université Paris Sud, Paris 11, 39 rue Camille-Desmoulins, F-94805, Villejuif, France. kroemer@orange.fr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42032295

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.